s6y

BRIGHT MINDS BIOSCIENCES INC.

Ticker
DRUG
CIK
1827401
Industry
Pharmaceutical Preparations

Ownership 17

  1. 4 Statement of changes in beneficial ownership of securities
  2. SC 13G Major Shareholders
  3. 4 Statement of changes in beneficial ownership of securities
  4. SC 13G/A Major Shareholders
  5. SC 13D/A Major Shareholders
  6. SC 13D/A Major Shareholders
  7. SC 13G Major Shareholders
  8. SC 13G Major Shareholders
  9. SC 13G Major Shareholders
  10. SC 13G/A Major Shareholders

All 17 ownership filings

Prospectus 6

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  4. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  5. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  6. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

Other 159

  1. SCHEDULE 13G/A
  2. SCHEDULE 13G/A
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. SCHEDULE 13G/A
  8. SCHEDULE 13G/A
  9. SCHEDULE 13D/A
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 159 other filings